DSIP (Delta Sleep-Inducing Peptide) vs Melanotan II

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

DSIP (Delta Sleep-Inducing Peptide)Melanotan II
CategoryPeptidesPeptides
Standard DoseResearch indicates 100-300 mcg administered before bedtime via subcutaneous injection or intranasal.Research indicates 250-500 mcg daily via subcutaneous injection during loading, reducing to 250 mcg 2-3 times weekly for maintenance.
Timing30-60 minutes before desired sleep onset. Evening only.Administer 4-6 hours before UV exposure for optimal tanning synergy. Can be taken at any time of day.
Cycle Duration2-4 week cycles with equal rest periods to prevent tolerance.Loading phase 1-2 weeks, then maintenance as long as desired. Pigmentation fades gradually upon discontinuation.
Evidence Levelanimal_plus_anecdotalmoderate_human

Mechanism

DSIP is a naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from rabbit brain hypothalamus in 1977. It modulates GABAergic neurotransmission by potentiating GABA-activated currents in hippocampal and cerebellar neurons while blocking NMDA-activated potentiation in cortical neurons. It also interacts with opioid-associated receptors, modulates serotonin and dopamine systems (increasing serotonin levels), and promotes delta wave (slow-wave) sleep through mechanisms that remain incompletely characterized.

Standard Dosing

Research indicates 100-300 mcg administered before bedtime via subcutaneous injection or intranasal.

Timing

30-60 minutes before desired sleep onset. Evening only.

Cycle Duration

2-4 week cycles with equal rest periods to prevent tolerance.

Side Effects

  • Morning grogginess
  • Vivid dreams
  • Mild headache
  • Transient hypotension

Contraindications

  • Sleep apnea (may worsen)
  • Respiratory depression risk
  • Pregnancy and breastfeeding

Best Stacking Partners

EpitalonSelank
B

Melanotan II

Peptides

Mechanism

Melanotan II is a synthetic cyclic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) that non-selectively agonizes melanocortin receptors MC1, MC3, MC4, and MC5. MC1R activation stimulates eumelanin synthesis through tyrosinase upregulation, producing tanning. MC3R activation in the CNS increases libido and produces erectile responses. MC4R activation suppresses appetite. The cyclic structure provides enhanced in vivo stability (half-life 1-2 hours) and increased blood-brain barrier permeability compared to linear alpha-MSH.

Standard Dosing

Research indicates 250-500 mcg daily via subcutaneous injection during loading, reducing to 250 mcg 2-3 times weekly for maintenance.

Timing

Administer 4-6 hours before UV exposure for optimal tanning synergy. Can be taken at any time of day.

Cycle Duration

Loading phase 1-2 weeks, then maintenance as long as desired. Pigmentation fades gradually upon discontinuation.

Side Effects

  • Nausea (common, especially during loading)
  • Facial flushing
  • Spontaneous erections
  • Appetite suppression
  • Darkening of existing moles (monitor closely)
  • Fatigue
  • New nevus formation

Contraindications

  • History of melanoma or atypical moles
  • Active skin cancer
  • Pregnancy and breastfeeding
  • Addison's disease
  • Pheochromocytoma

Best Stacking Partners

PT-141

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →